NJ Regulator Reverses Course on Curaleaf License Renewals, with Stiff Stipulations
In a dramatic reversal, regulators in New Jersey voted 4-1 Monday afternoon to renew Curaleaf’s adult-use licenses, up-ending their previous denial days earlier... Read more.
Is the Dormant Commerce Clause Losing Steam as a Means to Interstate Cannabis Trade?
Last year, the U.S. Constitution’s dormant commerce clause was successfully used to justify legal challenges to residency and social equity rules for marijuana... Read more.
Multi-State Divestitures Delay Cresco-Columbia Merger
Cresco Labs’ $2 billion acquisition of Columbia Care has been pushed back to this summer, but that should not be a surprise given the bureaucratic and logistic... Read more.
Curaleaf’s Undisclosed Ties to Sanctioned Oligarch Spur Regulatory Scrutiny
Curaleaf is betting its survival on the nascent East Coast markets, but could new investigations in at least three northeastern states strike a fatal blow to one... Read more.
Social Equity Fund’s Financing Woes Could Further Delay New York’s Slow Adult-Use Start
Questions about New York’s cannabis social equity fund persist months after missing the Sept. 1, 2022, deadline to secure $150 million in financing. The fund,... Read more.
